NutraCea Receives Purchase Order for $660,000

This order is expected to be shipped and booked in the current quarter. The initial order for the launch of the baby rice cereal line was previously shipped and booked in the fourth quarter of 2006. This order expands the initial order in both size and scope. The products are now on store shelves throughout the nation and the product category is expanding into the international market.

NutraCea Receives Purchase Order for $660,000

This order is expected to be shipped and booked in the current quarter. The initial order for the launch of the baby rice cereal line was previously shipped and booked in the fourth quarter of 2006. This order expands the initial order in both size and scope. The products are now on store shelves throughout the nation and the product category is expanding into the international market.

"Our product stands up against any national brand baby cereal in terms of price, taste, and integrity and is a great value for the consumer," said Margie Adelman, Senior Vice President of NutraCea. "We are delighted that our customer is happy with our product and as a result has requested line extensions as part of this order. In addition, we are currently discussing several other line extensions in this category, which include single and mixed grain cereals with the addition of fruits," Adelman added.

"This is clearly a significant opportunity for NutraCea and we intend to continue to explore expansion with other premium private label brands for our customers." said Leo Gingras, COO of NutraCea.

About NutraCea

NutraCea is a leader in stabilized rice bran nutrient research and dietary supplement development. Through its wholly owned subsidiary, RiceX, the Company manufactures and distributes products and food ingredients made from rice bran through its proprietary technology and processes. NutraCea has developed intellectual properties to create a range of proprietary product formulations, delivery systems and whole food nutrition products. The Company’s proprietary technology enables the creation of food and nutrition products from rice bran, normally an underutilized by-product of standard rice processing. In addition to its whole foods products, NutraCea develops families of health-promoting "nutraceuticals," including natural arthritis relief and cholesterol-lowering products. More information can be found in the Company's filings with the SEC and at its Web site http://www.NutraCea.com.

Forward Looking Statements

This release contains forward-looking statements. Actual results may differ from those projected due to a number of risks and uncertainties, including, but not limited to the matters specified in the Company's filings with the Securities and Exchange Commission. These statements are made based upon current expectations that are subject to risk and uncertainty. The Company does not undertake to update forward-looking statements in this news release to reflect actual results, changes in assumptions or changes in other factors affecting such forward-looking information. Assumptions and other information that could cause results to differ from those set forth in the forward-looking information can be found in the Company's filings with the Securities and Exchange Commission, including the company's most recent periodic report. NutraCea has no relationship or involvement with the American International Group or The Midland Company.

Back to top